National Health Performance FrameworkDomain 1- Health status

Domain 1- Health status

Dimensions of this framework

• Deaths

  Mortality rates and life expectancy measures.

  Indicators in this framework

  • National Healthcare Agreement: P18-Life expectancy, 2010
    Health, Superseded 08/06/2011
  • National Healthcare Agreement: P20-Potentially avoidable deaths, 2010
    Health, Superseded 08/06/2011
  • National Healthcare Agreement: P19-Infant/young child mortality rate, 2010
    Health, Superseded 08/06/2011
  • National Healthcare Agreement: P59-Age-standardised mortality by major cause of death, 2010
    Health, Superseded 08/06/2011
  • National Healthcare Agreement: PI 18-Life expectancy, 2011
    Health, Superseded 30/10/2011
  • National Healthcare Agreement: PI 19-Infant and young child mortality rate, 2011
    Health, Superseded 30/10/2011
  • National Healthcare Agreement: PI 59-Age-standardised mortality by major cause of death, 2011
    Health, Superseded 31/10/2011
  • National Healthcare Agreement: PI 20-Potentially avoidable deaths, 2011
    Health, Superseded 31/10/2011
  • National Healthcare Agreement: PI 59-Age-standardised mortality by major cause of death, 2012
    Health, Superseded 25/06/2013
  • National Healthcare Agreement: PI 18-Life expectancy, 2012
    Health, Superseded 25/06/2013
  • National Healthcare Agreement: PI 19-Infant and young child mortality rate, 2012
    Health, Superseded 25/06/2013
  • National Healthcare Agreement: PI 20-Potentially avoidable deaths, 2012
    Health, Superseded 25/06/2013
  • National Healthcare Agreement: PI 06-Life expectancy, 2013
    Health, Superseded 30/04/2014
  • National Healthcare Agreement: PI 07-Infant and young child mortality rate, 2013
    Health, Superseded 30/04/2014
  • National Healthcare Agreement: PI 16-Potentially avoidable deaths, 2013
    Health, Superseded 30/04/2014
  • National Healthcare Agreement: PI 07-Infant and young child mortality rate, 2014
    Health, Superseded 14/01/2015
  • National Healthcare Agreement: PI 16-Potentially avoidable deaths, 2014
    Health, Superseded 14/01/2015
  • National Healthcare Agreement: PI 06-Life expectancy, 2014
    Health, Superseded 14/01/2015
  • National Healthcare Agreement: PI 07-Infant and young child mortality rate, 2015
    Health, Superseded 08/07/2016
  • National Healthcare Agreement: PI 06-Life expectancy, 2015
    Health, Superseded 08/07/2016
  • National Healthcare Agreement: PI 16-Potentially avoidable deaths, 2015
    Health, Superseded 08/07/2016
  • National Healthcare Agreement: PI 08-Major causes of death, 2015
    Health, Superseded 08/07/2016
  • National Healthcare Agreement: PI 08-Major causes of death, 2014
    Health, Superseded 14/01/2015
  • National Healthcare Agreement: PI 08-Major causes of death, 2013
    Health, Superseded 30/04/2014
  • National Healthcare Agreement: PI 06–Life expectancy, 2016
    Health, Superseded 31/01/2017
  • National Healthcare Agreement: PI 07–Infant and young child mortality rate, 2016
    Health, Superseded 31/01/2017
  • National Healthcare Agreement: PI 08–Major causes of death, 2016
    Health, Superseded 31/01/2017
  • National Healthcare Agreement: PI 16–Potentially avoidable deaths, 2016
    Health, Superseded 31/01/2017
  • National Healthcare Agreement: PI 06–Life expectancy, 2017
    Health, Superseded 30/01/2018
  • National Healthcare Agreement: PI 07–Infant and young child mortality rate, 2017
    Health, Superseded 30/01/2018
  • National Healthcare Agreement: PI 08–Major causes of death, 2017
    Health, Superseded 30/01/2018
  • National Healthcare Agreement: PI 16–Potentially avoidable deaths, 2017
    Health, Superseded 30/01/2018
  • National Healthcare Agreement: PI 06–Life expectancy, 2018
    Health, Superseded 19/06/2019
  • National Healthcare Agreement: PI 07–Infant and young child mortality rate, 2018
    Health, Superseded 19/06/2019
  • National Healthcare Agreement: PI 08–Major causes of death, 2018
    Health, Superseded 19/06/2019
  • National Healthcare Agreement: PI 16–Potentially avoidable deaths, 2018
    Health, Superseded 19/06/2019
  • National Healthcare Agreement: PI 06–Life expectancy, 2019
    Health, Superseded 13/03/2020
  • National Healthcare Agreement: PI 07–Infant and young child mortality rate, 2019
    Health, Superseded 13/03/2020
  • National Healthcare Agreement: PI 08–Major causes of death, 2019
    Health, Superseded 13/03/2020
  • National Healthcare Agreement: PI 16–Potentially avoidable deaths, 2019
    Health, Superseded 13/03/2020
  • National Healthcare Agreement: PI 07–Infant and young child mortality rate, 2020
    Health, Standard 13/03/2020
  • National Healthcare Agreement: PI 16–Potentially avoidable deaths, 2020
    Health, Standard 13/03/2020
  • National Healthcare Agreement: PI 06–Life expectancy, 2020
    Health, Standard 13/03/2020
  • National Healthcare Agreement: PI 08–Major causes of death, 2020
    Health, Standard 13/03/2020
  • National Healthcare Agreement: PI 06–Life expectancy, 2021
    Health, Standard 03/07/2020
  • National Healthcare Agreement: PI 08–Major causes of death, 2021
    Health, Standard 03/07/2020
  • National Healthcare Agreement: PI 16–Potentially avoidable deaths, 2021
    Health, Standard 03/07/2020
  • National Healthcare Agreement: PI 07–Infant and young child mortality rate, 2021
    Health, Standard 03/07/2020
  • National Healthcare Agreement: PI 07–Infant and young child mortality rate, 2022
    Health, Standard 24/09/2021
  • National Healthcare Agreement: PI 08–Major causes of death, 2022
    Health, Standard 24/09/2021
  • National Healthcare Agreement: PI 16–Potentially avoidable deaths, 2022
    Health, Standard 24/09/2021
  • National Healthcare Agreement: PI 06–Life expectancy, 2022
    Health, Standard 24/09/2021

• Health conditions

  Prevalence of disease, disorder, injury or trauma or other health-related states.

  Indicators in this framework

  • National Healthcare Agreement: P04-Incidence of selected cancers, 2010
    Health, Superseded 08/06/2011
  • National Healthcare Agreement: P03-Incidence of end-stage kidney disease, 2010
    Health, Superseded 08/06/2011
  • National Healthcare Agreement: P63-Children's hearing loss, 2010
    Health, Superseded 08/06/2011
  • National Healthcare Agreement: P01-Proportion of babies born with low birth weight, 2010
    Health, Superseded 08/06/2011
  • National Healthcare Agreement: PB 01-Reduce the age-adjusted prevalence rate for Type 2 diabetes to 2000 levels (equivalent to a national prevalence rate (for 25 years and over) of 7.1 per cent) within 15 years (Baseline specification), 2011
    Health, Superseded 30/10/2011
  • National Healthcare Agreement: P02-Incidence of sexually transmitted infections and blood-borne viruses, 2010
    Health, Superseded 08/06/2011
  • National Healthcare Agreement: PI 02-Incidence of sexually transmissible infections and blood-borne viruses, 2011
    Health, Superseded 30/10/2011
  • National Healthcare Agreement: PI 03-Incidence of end-stage kidney disease, 2011
    Health, Superseded 30/10/2011
  • National Healthcare Agreement: PI 04-Incidence of selected cancers, 2011
    Health, Superseded 30/10/2011
  • National Healthcare Agreement: PB 01-Reduce the age-adjusted prevalence rate for Type 2 diabetes to 2000 levels (equivalent to a national prevalence rate (for 25 years and over) of 7.1 per cent) within 15 years (Baseline specification), 2012
    Health, Superseded 25/06/2013
  • National Healthcare Agreement: PI 63-Children's hearing loss, 2012
    Health, Retired 25/06/2013
  • National Healthcare Agreement: PI 02-Incidence of sexually transmissible infections and blood-borne viruses, 2012
    Health, Retired 25/06/2013
  • National Healthcare Agreement: PI 03-Incidence of end-stage kidney disease, 2012
    Health, Retired 25/06/2013
  • National Healthcare Agreement: PI 04-Incidence of selected cancers, 2012
    Health, Superseded 25/06/2013
  • National Healthcare Agreement: PB c-Better health: reduce the age-adjusted prevalence rate for Type 2 diabetes to 2000 levels (equivalent to a national prevalence rate (for 25 years and over) of 7.1 per cent) by 2023, 2013
    Health, Superseded 30/04/2014
  • National Healthcare Agreement: PI 02-Incidence of selected cancers, 2013
    Health, Superseded 30/04/2014
  • National Healthcare Agreement: PI 02-Incidence of selected cancers, 2014
    Health, Superseded 14/01/2015
  • National Healthcare Agreement: PI 02-Incidence of selected cancers, 2015
    Health, Superseded 08/07/2016
  • National Healthcare Agreement: PB c-Better health: reduce the age-adjusted prevalence rate for Type 2 diabetes to 2000 levels (equivalent to a national prevalence rate (for 25 years and over) of 7.1 per cent) by 2023, 2015
    Health, Superseded 08/07/2016
  • National Healthcare Agreement: PB c-Better health: reduce the age-adjusted prevalence rate for Type 2 diabetes to 2000 levels (equivalent to a national prevalence rate (for 25 years and over) of 7.1 per cent) by 2023, 2014
    Health, Superseded 14/01/2015
  • National Healthcare Agreement: PI 63-Children's hearing loss, 2011
    Health, Superseded 31/10/2011
  • National Healthcare Agreement: PI 02–Incidence of selected cancers, 2016
    Health, Superseded 31/01/2017
  • National Healthcare Agreement: PB c–Better health: reduce the age-adjusted prevalence rate for Type 2 diabetes to 2000 levels (equivalent to a national prevalence rate (for 25 years and over) of 7.1 per cent) by 2023, 2016
    Health, Superseded 31/01/2017
  • National Healthcare Agreement: PI 02–Incidence of selected cancers, 2017
    Health, Superseded 30/01/2018
  • National Healthcare Agreement: PB c–Better health: reduce the age-adjusted prevalence rate for Type 2 diabetes to 2000 levels (equivalent to a national prevalence rate (for 25 years and over) of 7.1 per cent) by 2023, 2017
    Health, Superseded 30/01/2018
  • National Healthcare Agreement: PB c–Better health: reduce the age-adjusted prevalence rate for Type 2 diabetes to 2000 levels (equivalent to a national prevalence rate (for 25 years and over) of 7.1 per cent) by 2023, 2018
    Health, Superseded 19/06/2019
  • National Healthcare Agreement: PI 02–Incidence of selected cancers, 2018
    Health, Superseded 19/06/2019
  • National Healthcare Agreement: PI 02–Incidence of selected cancers, 2019
    Health, Superseded 13/03/2020
  • National Healthcare Agreement: PB c–Better health: reduce the age-adjusted prevalence rate for Type 2 diabetes to 2000 levels (equivalent to a national prevalence rate (for 25 years and over) of 7.1 per cent) by 2023, 2019
    Health, Superseded 13/03/2020
  • National Healthcare Agreement: PB c–Better health: reduce the age-adjusted prevalence rate for Type 2 diabetes to 2000 levels (equivalent to a national prevalence rate (for 25 years and over) of 7.1 per cent) by 2023, 2020
    Health, Standard 13/03/2020
  • National Healthcare Agreement: PI 02–Incidence of selected cancers, 2020
    Health, Standard 13/03/2020
  • National Healthcare Agreement: PB c–Better health: reduce the age-adjusted prevalence rate for Type 2 diabetes to 2000 levels (equivalent to a national prevalence rate (for 25 years and over) of 7.1 per cent) by 2023, 2021
    Health, Standard 03/07/2020
  • National Healthcare Agreement: PI 02–Incidence of selected cancers, 2021
    Health, Standard 16/09/2020
  • National Healthcare Agreement: PB c–Better health: reduce the age-adjusted prevalence rate for Type 2 diabetes to 2000 levels (equivalent to a national prevalence rate (for 25 years and over) of 7.1 per cent) by 2023, 2022
    Health, Standard 24/09/2021
  • National Healthcare Agreement: PI 02–Incidence of selected cancers, 2022
    Health, Standard 24/09/2021

• Human functions

  Alterations to body structure or function (impairment), activity limitations and restrictions on participation.

• Wellbeing

  Measures of physical, mental and social wellbeing of individuals.